| Record ID | marc_records_scriblio_net/part20.dat:180374159:1128 |
| Source | Scriblio |
| Download Link | /show-records/marc_records_scriblio_net/part20.dat:180374159:1128?format=raw |
LEADER: 01128cam 2200301 a 4500
001 89114490 //r93
003 DLC
005 19930525092505.2
008 890215s1988 gw b 000 0 eng d
010 $a 89114490 //r93
015 $aGB88-52943
020 $a3527273700 (Weinheim)
020 $a0895738708 (New York)
040 $aUk$cDLC$dDLC
042 $alccopycat
050 04 $aRM666.G44$bT63 1988
082 04 $a615/.32992$219
245 00 $aTobramycin profile /$ccompiled by Robert A.A. Maes and Michael Oellerich.
260 $aWeinheim, F.R.G. ;$bNew York :$bVCH,$cc1988.
300 $aviii, 30 p. ;$c21 cm.
490 1 $aReport 9 of the Senate Commission for Clinical-Toxicological Analysis,$x0930-7958 =$aMitteilung 9 der Senatskommission für Klinisch-toxikologische Analytik
504 $aIncludes bibiographical references (p. 23-25).
650 0 $aGentamicin.
650 0 $aTobramycin.
700 10 $aMaes, R. A. A.$q(Robert A. A.),$d1937-
700 10 $aOellerich, Michael.
710 20 $aDeutsche Forschungsgemeinschaft.
830 0 $aReport ... of the Senate Commission for Clinical-Toxicological Analysis ;$v9.